Most of what we do — the websites we visit, the places we go, the TV shows we watch, the products we buy — has become fair game for advertisers. Now, thanks to internet-connected devices in the home like smart thermometers, ads we see may be determined by something even more personal: our health

Quick Read

Desperate & Duped?

October 24, 2018

GoFundMe means big bucks for dubious care. People seeking dubious, potentially harmful treatment for cancer and other ailments raised nearly $7 million over two years from crowdfunding sites, a study found

Quick Read

Top researchers at Memorial Sloan Kettering Cancer Center have filed at least seven corrections with medical journals recently, divulging financial relationships with health care companies that they did not previously disclose

Quick Read

And patients are the worse off. Ed Silverman writes, Seeking to recover from sensational marketing scandals, GlaxoSmithKline did something unexpected five years ago — the company promised it would no longer pay doctors to promote its medicines, which had been a long-standing industry practice

Quick Read

And drug makers would still make healthy profits. As prices for diabetes treatments continue to roil consumers, a new study suggests that manufacturers could make both human and analog insulins at low costs and still pocket a profit.

Quick Read

A HANDFUL OF years ago, a small pharmaceutical company quietly acquired the rights to an old but commonly used antibiotic. Few noticed until last week, when the new owner did something that’s recently become common in the world of pharmaceuticals: It abruptly raised the price. A lot

Quick Read

In the United States, pharmaceutical companies have built a system which supports high costs for HIV drugs. But that may be starting to change

Quick Read

Settlement ensures care of 2,200 state prisoners with hepatitis C. Inmates will no longer be required to undergo drug or alcohol treatment as a precondition for care

Quick Read